Dennis Christoph Harrer

RNA-transfection of γ/δ T cells with a chimeric antigen receptor or an α/β T-cell receptor: a safer alternative to genetically engineered α/β T cells for the immunotherapy of melanoma

Dennis Christoph Harrer, Bianca Simon, Shin‐ichiro Fujii et al. · BMC Cancer · 2017 · 116 citations · Full text

Life Sciences, Biotechnology, Immunology +17

The si<scp>RNA</scp>‐mediated downregulation of <scp>PD</scp>‐1 alone or simultaneously with <scp>CTLA</scp>‐4 shows enhanced in vitro <scp>CAR</scp>‐T‐cell functionality for further clinical development towards the potential use in immunotherapy of melanoma

Bianca Simon, Dennis Christoph Harrer, Beatrice Schuler‐Thurner et al. · Experimental Dermatology · 2018 · 84 citations

Medicine, Immunology, Oncology +17

Arming T Cells with a gp100-Specific TCR and a CSPG4-Specific CAR Using Combined DNA- and RNA-Based Receptor Transfer

Bianca Simon, Dennis Christoph Harrer, Beatrice Schuler‐Thurner et al. · Cancers · 2019 · 34 citations · Full text

Life Sciences, Immunology, Molecular Biology +17

CSPG4-Specific CAR T Cells for High-Risk Childhood B Cell Precursor Leukemia

Dennis Christoph Harrer, Gerold Schuler, Jan Dörrie et al. · International Journal of Molecular Sciences · 2019 · 23 citations · Full text

Life Sciences, Cell Biology, Immunology +15

Enhancing lentiviral transduction to generate melanoma-specific human T cells for cancer immunotherapy

Bianca Simon, Dennis Christoph Harrer, Christian Thirion et al. · Journal of Immunological Methods · 2019 · 22 citations

Life Sciences, Immunology, Oncology +16